Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/07/2012 | WO2012072682A1 Method for evaluating the vital prognosis of a subject in a critical condition |
06/07/2012 | WO2012072595A1 Platelet factor 4 variant for the prognosis of cardiovascular outcome in patients having heart disease |
06/07/2012 | WO2012072582A1 Method for detecting in situ the presence of explosives in a gaseous medium |
06/07/2012 | WO2012072516A1 Barf1 a diagnostic and prognostic marker for epstein-barr virus (ebv)-associated lymphoma |
06/07/2012 | WO2012072515A2 Lmp1 a diagnostic and prognostic marker for epstein-barr virus (ebv)-associated lymphoma |
06/07/2012 | WO2012072468A1 Deposition aid for the manual deposition of mass spectrometric samples |
06/07/2012 | WO2012072442A1 A processor unit for processing and controlling a preparation of a blood sample and a method |
06/07/2012 | WO2012072106A1 Determination of sulphur dioxide in a liquid |
06/07/2012 | WO2012071716A1 Integrated analysis device for simultaneously detecting exhaled breath condensates (ebcs) and volatile organic compounds (vocs) in human exhaled breath |
06/07/2012 | WO2012071649A1 Covalently dimerized bivalent binding agents |
06/07/2012 | WO2012071631A1 Improved light-emitting molecules |
06/07/2012 | WO2012071629A1 Device and process for passive sampling |
06/07/2012 | WO2012071605A1 Process for preparing gold nanoparticles |
06/07/2012 | WO2012052752A3 Fluid discrimination apparatus and method |
06/07/2012 | WO2012051612A3 System for monitoring underwater characteristics |
06/07/2012 | WO2012050645A9 Pathogen detection |
06/07/2012 | WO2012049491A3 Analyte extraction apparatus and method |
06/07/2012 | WO2012044794A3 Detection kit |
06/07/2012 | WO2012040456A3 Human b1 cells and uses thereof |
06/07/2012 | WO2012040059A3 Compositions and methods for modulating desnutrin-mediated adipocyte lipolysis |
06/07/2012 | WO2012037030A3 Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices |
06/07/2012 | WO2012034132A3 Inhibitors of human ezh2, and methods of use thereof |
06/07/2012 | WO2012034076A3 Etv1 as a diagnostic, prognostic and therapeutic target for gastrointestinal stromal tumors |
06/07/2012 | WO2012031752A8 Tuberculosis mutants |
06/07/2012 | WO2012028719A3 Electrochemical detection of analyte |
06/07/2012 | WO2012027361A3 Automated denaturation graphs |
06/07/2012 | WO2012024194A3 Microfluidic cell separation in the assay of blood |
06/07/2012 | WO2012023071A3 Dehydration sensors with ion-responsive and charged polymeric surfactants |
06/07/2012 | WO2012023070A3 Dehydration sensors having buffered inks |
06/07/2012 | WO2012020123A9 Neuropilin as a biomarker for bevacizumab combination therapies |
06/07/2012 | WO2012009774A3 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods |
06/07/2012 | WO2012006534A4 Methods, compositions and kits for diagnosing and treating alzheimer's disease using mitochondrial co3 gene mutations |
06/07/2012 | WO2012006391A3 Modulators for sirt5 and assays for screening same |
06/07/2012 | WO2012005719A3 Oral health index |
06/07/2012 | WO2011105721A3 Preparation method of antigen-immobilized immunofluorescence slide, and immunofluorescence slide prepared thereby |
06/07/2012 | WO2011061944A8 Fluoroimmunoassay method |
06/07/2012 | WO2011060528A8 Heteropeptides useful for reducing nonspecific adsorption |
06/07/2012 | WO2011057123A8 Germline stem cell banking system |
06/07/2012 | US20120144516 Transgenic sugar beet event gm rz13 |
06/07/2012 | US20120144504 Caspase-8 and skin disease |
06/07/2012 | US20120143872 Computer Algorithm for Automatic Allele Determination from Fluorometer Genotyping Device |
06/07/2012 | US20120142904 Protein renaturation microfluidic devices and methods of making and using the same |
06/07/2012 | US20120142903 Methods For Detecting And Analyzing N-Glycolylneuraminic Acid (NEU5GC) In Biological Materials |
06/07/2012 | US20120142896 Modified human interferon polypeptides and their uses |
06/07/2012 | US20120142894 Identification, Optimization and Use of Shared HLA-B*0702 Epitopes for Immunotherapy |
06/07/2012 | US20120142784 Lysine-specific demethylase 1(lsd1) is a biomarker for breast cancer |
06/07/2012 | US20120142758 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene |
06/07/2012 | US20120142701 Compounds and methods for the treatment of proliferative diseases |
06/07/2012 | US20120142632 Diagnostic and prognostic assay |
06/07/2012 | US20120142624 Akt phosphorylation at ser473 as an indicator for taxane-based chemotherapy |
06/07/2012 | US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions |
06/07/2012 | US20120142608 Rca locus analysis to assess susceptibility to amd and mpgnii |
06/07/2012 | US20120142607 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
06/07/2012 | US20120142606 Tumor targeting peptides, therapeutic and diagnostic compositions compressing the peptides |
06/07/2012 | US20120142585 Leptin antagonist and methods of use |
06/07/2012 | US20120142559 Biomarkers and parameters for hypertensive disorders of pregnancy |
06/07/2012 | US20120142552 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence |
06/07/2012 | US20120142550 Vanin 1 as a Peripheral Blood Oxidative Stress Sensor |
06/07/2012 | US20120142549 Raf gene fusions |
06/07/2012 | US20120142547 Polypeptide immobilization |
06/07/2012 | US20120142545 Solid phase and catalyzed enabled automated isotope dilution and speciated isotope dilution mass spectrometry |
06/07/2012 | US20120142544 Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies |
06/07/2012 | US20120142543 Methods to assess treatment outcomes in Reward Deficiency Syndrome (RDS) behaviors utilizing expression profiling |
06/07/2012 | US20120142120 Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction |
06/07/2012 | US20120142115 Method and apparatus for determination of system parameters for reducing crude unit corrosion |
06/07/2012 | US20120142114 Methods and Apparatus for Measuring Blood Coagulation |
06/07/2012 | US20120142113 Method and apparatus for determination of system parameters for reducing crude unit corrosion |
06/07/2012 | US20120142112 Electroluminescent diode sensor |
06/07/2012 | US20120142111 Nanomaterial-containing signaling compositions for assay of flowing liquid streams and geological formations and methods for use thereof |
06/07/2012 | US20120142092 Rat embryonic stem cell |
06/07/2012 | US20120142085 Systems for rapid identification of pathogens in humans and animals |
06/07/2012 | US20120142084 Graphical interface for analyte meter |
06/07/2012 | US20120142079 Minicell based delivery of biologically active compounds |
06/07/2012 | US20120142044 Methods for ionophorically screening pore forming bacterial protein toxins and receptors |
06/07/2012 | US20120142035 Calibrator/Control for Simultaneous Assay of Proteins Capable of Complexing With One Another |
06/07/2012 | US20120142034 Pvdf membranes |
06/07/2012 | US20120142033 Method for extraction and purification of recombinant proteins from transgenic plants |
06/07/2012 | US20120142031 Real time electronic cell sensing systems and applications for cell-based assays |
06/07/2012 | US20120142030 Biomarkers for Follicular Thyroid Carcinoma and Methods of Use |
06/07/2012 | US20120142029 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
06/07/2012 | US20120142028 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
06/07/2012 | US20120142027 Compositions and Methods for Modulating the Immune Response and Identifying Immunomodulators |
06/07/2012 | US20120142026 Assay Devices with Integrated Sample Dilution and Dilution Verification and Methods of Using Same |
06/07/2012 | US20120142025 Ratiometric Immunoassay Method and Blood Testing Device |
06/07/2012 | US20120142024 Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities |
06/07/2012 | US20120142023 Proteins and method for detection of lyme disease |
06/07/2012 | US20120142022 Glycosylated mammalian ngal and use thereof |
06/07/2012 | US20120142020 Sample Metering Device and Assay Device with Integrated Sample Dilution |
06/07/2012 | US20120142019 Sample Metering Device and Assay Device with Integrated Sample Dilution |
06/07/2012 | US20120142017 Biosensor device and manufacturing method thereof |
06/07/2012 | US20120142016 Array-based bioactivated nanopore devices |
06/07/2012 | US20120142012 Biomarker for colorectal cancer |
06/07/2012 | US20120142008 Methods for evaluating gastrointestinal absorption of chemicals |
06/07/2012 | US20120142007 Stable compositions for nucleic acid amplification and sequencing |
06/07/2012 | US20120142006 Massive parallel method for decoding dna and rna |
06/07/2012 | US20120142002 Spontaneously immortalized multicomponent mesenchymal cell-line derived from mouse subcutaneous adipose tissue: tool for regenerative medicine and bioactive molecules and/or drugs screening |
06/07/2012 | US20120141998 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
06/07/2012 | US20120141997 Compositions And Methods For Free-Solution Conjugate Nucleic Acid Analysis |
06/07/2012 | US20120141996 Cystic fibrosis transmembrane conductance regulator gene mutations |
06/07/2012 | US20120141994 Methods and compositions for prognosing and detecting age-related macular degeneration |